Advertisement

Topics

HELSINN HEALTHCARE S.A. Company Profile

00:34 EDT 25th September 2017 | BioPortfolio

Helsinn's strategy is focused on three activities Integrated Licensing Helsinn uses an innovative approach to develop and market new pharmaceutical products:
INTEGRATED LICENSING
Helsinn adds scientific and market value to its products.
Integrated Manufacturing Helsinn is a qualified developer and producer of Active Pharmaceutical Ingredients (APIs), High Potency Active Ingredients (HPAIs) and finished dosage forms.
Helsinn delivers a ready-to-market product to its partners.
Pharmaceutical Business
Helsinn is engaged in local sales and marketing in the Irish market with two sales teams.

Location

via Pian Scairolo 9
Pazzallo
6912
Switzerland

Contact

Phone: 41 91 985.21.21
Fax: 41 91 993.21.22


News Articles [907 Associated News Articles listed on BioPortfolio]

Helsinn at the 31st Annual J.P. Morgan Healthcare Conference, January 8, 2013

LUGANO, Switzerland, January 7, 2013 /PRNewswire/ -- Helsinn Group is pleased to announce that tomorrow (Tuesday, January 8th, 2013) at 9am Pacific Standard Time (18:00 Swiss time), Dr. Riccardo Brag...

Helsinn Passes Cancer Care GLP-2 Analog Elsiglutide Back to Zealand Pharma

Swiss pharmaceutical group Helsinn has passed back to Zealand Pharma all rights to the latter’s glucagon-like peptide-2 (GLP-2) analogue, elsiglutide, which it was developing for treating chemothera...

Co-promotion agreement signed for cancer therapy Zykadia

Swiss-based pharma group Helsinn has revealed its US subsidiary (Helsinn Therapeutics) has signed a co-promotion agreement with Novartis for Zykadia

Helsinn and MEI begin dosing in Phase II combination trial to treat MDS

Swiss pharmaceutical group Helsinn and US-based oncology firm MEI Pharma have begun dosing patients in a Phase II clinical trial of pracinostat and azacitidine combination for the treatment of patient...

Helsinn Group presents phase III data in NEPA at MASCC/ISOO Congress

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, has announced that data showing the non-inferiority of NEPA (netupitant/palonestron) versus a 3-day oral aprepit...

Helsinn and MEI Pharma begin dosing in Phase III combination trial for AML

Swiss pharmaceutical group Helsinn and US-based oncology firm MEI Pharma have begun dosing patients in a Phase III clinical trial of pracinostat and azacitidine combination to treat adults with newly ...

Purdue Pharma to distribute Helsinn’s CINV injection Aloxi in Canada

Canadian research-based pharmaceutical firm Purdue Pharma has entered a distribution and licence agreement to distribute, promote, market and sell Swiss pharmaceutical group Helsinn’s Aloxi (palonos...

CHMP recommends against Helsinn's Adlumiz

Drugs and Medications [446 Associated Drugs and Medications listed on BioPortfolio]

Bacti-stat [Ecolab Inc.]

Drug Facts

Oxygen [Mon HealthCare]

oxygen

Isagel [Coloplast Manufacturing US, LLC]

Isagel HandwashingNo-Rinse, Antiseptic Hand Cleansing Gel with Added Moisturizers

Endure 200 [Ecolab Inc.]

Drug Facts

Tiger balm [Haw Par Healthcare Ltd.]

TIGER BALM PAIN RELIEVING LARGE PATCH

Clinical Trials [785 Associated Clinical Trials listed on BioPortfolio]

My Life, My Healthcare

This study is designed to answer the following questions: "Is the My Life, My Healthcare Discussion Aid feasible for use in primary care? Does it positively impact patient and healthcare t...

Asymptomatic Flu Project

Although clinical presentation of influenza is often symptomatic, asymptomatic cases also occur. The knowledge of the incidence of asymptomatic influenza among healthcare workers is very i...

Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes Care

Recently, we generated a new multidisciplinary ubiquitous healthcare system by upgrading our clinical decision supporting system (CDSS) rule engine, and integrating a physical activity-mon...

Implementation of Medical Weight Management by Telemedicine

As the prevalence and associated healthcare costs of obesity continue to increase, the need for obesity treatments that contribute to weight loss maintenance are needed. Through the functi...

Seroprevalence of MERS-CoV IgG in Healthcare Workers

The investigators aim to do serosurvey of healthcare-personnel who had participated in treatment of confirmed patients of Middle-East respiratory syndrome. The investigators collected the ...

Companies [1719 Associated Companies listed on BioPortfolio]

HELSINN HEALTHCARE S.A.

Helsinn's strategy is focused on three activities Integrated Licensing Helsinn uses an innovative approach to develop and market new pharmaceutical products:INTEGRATED LICENSINGHelsinn adds scient...

Helsinn Healthcare SA

Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland, and subsidiaries in USA and Ireland. Helsinn's unique business model is focused on the licensing of phar...

Helsinn Group and DARA BioSciences, Inc.

Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland, and operating subsidiaries in Ireland and the United States. Helsinn’s business mo...

Zelis™ Healthcare

Zelis Healthcare is a healthcare information technology company and market-leading provider of end-to-end healthcare claims cost management and payments solutions including networ...

Zelis Healthcare

Zelis Healthcare is a healthcare information technology company and market-leading provider of end-to-end healthcare claims cost management and payments solutions including networ...

More Information about "HELSINN HEALTHCARE S.A." on BioPortfolio

We have published hundreds of HELSINN HEALTHCARE S.A. news stories on BioPortfolio along with dozens of HELSINN HEALTHCARE S.A. Clinical Trials and PubMed Articles about HELSINN HEALTHCARE S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HELSINN HEALTHCARE S.A. Companies in our database. You can also find out about relevant HELSINN HEALTHCARE S.A. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record